Published in Metabolism on November 01, 1987
Separation and quantitation of subclasses of human plasma high density lipoproteins by a simple precipitation procedure. J Lipid Res (1982) 3.02
Interleukin 1 induces endothelial cell procoagulant while suppressing cell-surface anticoagulant activity. Proc Natl Acad Sci U S A (1986) 2.43
The apolipoprotein B gene is constitutively expressed in HepG2 cells: regulation of secretion by oleic acid, albumin, and insulin, and measurement of the mRNA half-life. J Lipid Res (1989) 1.72
Polypeptide composition of rat high density lipoprotein: characterization by SDS-gel electrophoresis. Biochem Biophys Res Commun (1974) 1.38
Colloidal gold--low density lipoprotein conjugates as membrane receptor probes. Proc Natl Acad Sci U S A (1981) 1.36
Platelet-activating factor antagonists. Annu Rev Pharmacol Toxicol (1987) 1.36
Stimulation of aortic smooth muscle cell mitogenesis by serotonin. Proc Natl Acad Sci U S A (1986) 1.33
Transport of lysolecithin by albumin in human and rat plasma. J Lipid Res (1965) 1.32
Factor-IX deficiency in the nephrotic syndrome. Lancet (1967) 1.30
Effects of high sucrose diets and 4-aminopyrazolopyrimidine on serum lipids and lipoproteins in the rat. J Lipid Res (1971) 1.28
Characterization of the apolipoproteins of rat plasma lipoproteins. Biochemistry (1977) 1.27
Extrahepatic synthesis of lipoproteins of plasma and chyle: role of the intestine. J Clin Invest (1966) 1.20
Inhibition of PAF-induced systemic responses in the rat, guinea pig, dog and primate by the receptor antagonist SRI 63-441. Thromb Haemost (1986) 1.09
Serum lipoproteins and apolipoproteins in rats with streptozotocin-induced diabetes. J Clin Invest (1976) 1.07
Serum lipoproteins of normal and cholesterol-fed rats. J Lipid Res (1973) 1.05
Colloidal gold: a pluripotent receptor probe. Proc Soc Exp Biol Med (1983) 1.04
Plasma lipids and lipoproteins and the incidence of cardiovascular disease in the very elderly. The Bronx Aging Study. Arterioscler Thromb (1992) 1.04
Platelet-derived growth factor labeled to colloidal gold for use as a mitogenic receptor probe. Eur J Cell Biol (1984) 1.00
Hyperlipoproteinemia in streptozotocin-treated rats. Diabetes (1976) 0.99
The uptake of chylomicron remnants and very low density lipoprotein remnants by the perfused rat liver. J Biol Chem (1984) 0.99
Hepatic binding and internalization of low density lipoprotein-gold conjugates in rats treated with 17 alpha-ethinylestradiol. J Cell Biol (1981) 0.99
Effect of platelet activating factor on endothelial permeability to plasma macromolecules. Immunopharmacology (1984) 0.97
History of the Journal of Lipid Research. J Lipid Res (1984) 0.92
Inhibition and reversal of endotoxin-, aggregated IgG- and paf-induced hypotension in the rat by SRI 63-072, a paf receptor antagonist. Immunopharmacology (1986) 0.91
Serum lipids and lipoproteins in advanced age. Intraindividual changes. Ann Epidemiol (1994) 0.91
Lipoprotein synthesis and fatty acid mobilization in rats after partial hepatectomy. Biochim Biophys Acta (1971) 0.91
A hepatocyte receptor for high-density lipoproteins specific for apolipoprotein A-I. J Biol Chem (1984) 0.91
The uptake of the apoprotein and cholesteryl ester of high-density lipoproteins by the perfused rat liver. Biochim Biophys Acta (1987) 0.90
Alterations of lipoprotein metabolism in orotic acid-induced fatty liver. Am J Pharm Sci Support Public Health (1966) 0.90
The design and use of a simple device for rapid quench-freezing of biological samples. J Microsc (1981) 0.90
Turnover of cholesteryl esters of plasma lipoproteins in the rat. J Lipid Res (1967) 0.90
Effects of S-salbutamol on human isolated bronchus. Pulm Pharmacol Ther (1998) 0.89
Clinical endoscopic evaluation of the gastroduodenal tolerance to (R)- ketoprofen, (R)- flurbiprofen, racemic ketoprofen, and paracetamol: a randomized, single-blind, placebo-controlled trial. J Clin Pharmacol (1998) 0.88
Apoproteins of high density lipoproteins in the urine of normal subjects. J Lipid Res (1979) 0.88
Erythropoietic uroporphyria of Gunther first presenting at 58 years with positive family studies. Br Med J (1975) 0.87
Effect of clofibrate on lipoprotein metabolism in hyperlipidemic rats. J Clin Invest (1972) 0.87
Butvar B-98 as a thin support film. Ultramicroscopy (1979) 0.87
Plasma triglycerides and cholesterol in diabetic ketosis. Arch Intern Med (1989) 0.86
In vitro and in vivo pharmacological profiles of the PAF receptor antagonist SRI 63-675. Thromb Haemost (1987) 0.85
Gold labeling of thrombin and ultrastructural studies of thrombin-gold conjugate binding by fibrin. Anal Biochem (1985) 0.84
Membrane-bound lipoprotein lipase on human monocyte-derived macrophages: localization by immunocolloidal gold technique. Biochim Biophys Acta (1988) 0.84
Lipid metabolism in diabetes mellitus. Am J Med (1979) 0.84
Vascular responses of platelet-activating factor in the Cebus apella primate and inhibitory profiles of antagonists SRI 63-072 and SRI 63-119. Immunopharmacology (1986) 0.84
Suppression of rat carotid lesion development by the calcium channel blocker PN 200-110. Am J Pathol (1986) 0.82
Effect of enantiomeric forms of albuterol on stimulated secretion of granular protein from human eosinophils. Pulm Pharmacol Ther (1997) 0.82
Isolation and lipid-binding properties of rat apolipoprotein A-IV. Biochim Biophys Acta (1985) 0.82
Activity and regulation of low density lipoprotein receptors in a human hepatoblastoma cell line. Hepatology (1985) 0.82
Cardiovascular complications. Diabetes (1982) 0.81
Glycation of high-density lipoprotein does not increase its susceptibility to oxidation or diminish its cholesterol efflux capacity. Metabolism (1999) 0.81
The clinical significance of the plasma high density lipoproteins. Med Clin North Am (1982) 0.81
Serum lipoproteins of diabetic rats fed a high cholesterol diet. Diabetes (1980) 0.81
Biological properties of the antagonist SRI 63-441 in the PAF and endotoxin models of hypotension in the rat and dog. Immunopharmacology (1987) 0.80
Evidence for distinct systemic extravasation effects of platelet activating factor, leukotrienes B4, C4, D4 and histamine in the guinea pig. Prostaglandins Leukot Med (1986) 0.80
Prevention of non-specific airway hyperreactivity after allergen challenge in guinea-pigs by the PAF receptor antagonist SDZ 64-412. Br J Pharmacol (1990) 0.80
Characterization of the specific binding of rat apolipoprotein E-deficient HDL to rat hepatic plasma membranes. Biochim Biophys Acta (1987) 0.79
Plasma lipoproteins and apolipoproteins. Ann N Y Acad Sci (1976) 0.79
Evaluation of dose and route effects of platelet activating factor-induced extravasation in the guinea pig. Thromb Haemost (1984) 0.79
The mechanism of inhibition of lipoprotein synthesis by orotic acid. Biochem Biophys Res Commun (1965) 0.79
Antitumor activity of SRI 62-834, a cyclic ether analog of ET-18-OCH3. Lipids (1987) 0.79
A circulating anticoagulant specific for factor V. Pathology (1969) 0.79
Effects of oscillatory mechanical disturbance on macromolecular uptake by arterial wall. Arteriosclerosis (1982) 0.78
Ultrastructural studies of endothelial and platelet receptor binding of thrombin-colloidal gold probes. Eur J Cell Biol (1986) 0.78
Colloidal gold labeling studies related to vascular and endothelial function, hemostasis and receptor-mediated processing of plasma macromolecules. Eur J Cell Biol (1987) 0.78
Effect of diabetes on the metabolism of triacylglycerol-rich lipoproteins. Biochem Soc Trans (1989) 0.78
Strains of Fusidia which can be mistaken for Actinomycetes. Mycologia (1977) 0.78
Preclinical pharmacology and possible mechanism of action of the novel antitumor agent 5-(4'-piperidinomethylphenyl)-2,3-dihydroimidazo [2,1-a]isoquinoline. Arzneimittelforschung (1995) 0.77
The effect of glipizide on HDL and HDL subclasses. Diabetes Res (1986) 0.77
Oxidation of ruthenium red for use as an intercellular tracer. Histochemistry (1981) 0.77
Evaluation of the effect of a platelet activating factor antagonist on platelet activating factor and Ascaris antigen-induced airway responses in rhesus monkeys. J Lab Clin Med (1987) 0.77
Effects of 17 alpha-ethinyl estradiol on the serum lipoproteins of cholesterol-fed diabetic rats. J Biol Chem (1980) 0.77
Evidence for a direct effect on vascular permeability of platelet-activating factor induced hemoconcentration in the guinea pig. Thromb Haemost (1985) 0.77
Antitumor activity of 5-aryl-2,3-dihydroimidazo[2,1-a]isoquinolines. J Med Chem (1995) 0.77
Receptor-mediated binding, endocytosis and cellular processing of macromolecules conjugated with colloidal gold. Scanning Microsc (1987) 0.77
Experiences in the use of fibrinolytic agents in Behcet's syndrome. Australas J Dermatol (1972) 0.76
Lipoproteins as risk factors for coronary heart disease. Bull N Y Acad Med (1982) 0.75
Evans blue (T-1824) and albumin clearances. J Appl Physiol (1985) (1992) 0.75
Biochemical and morphologic studies on diabetic rats: effects of sucrose-enriched diet in rats with pancreatic islet transplants. Proc Natl Acad Sci U S A (1979) 0.75
Effects of RS-albuterol on the development of antigen-mediated airway hyperreactivity in guinea pigs. Clin Rev Allergy Immunol (1996) 0.75
Terbinafine inhibits the mitogenic response to platelet-derived growth factor in vitro and neointimal proliferation in vivo. J Pharmacol Exp Ther (1989) 0.75
Synthesis and pharmacology of a novel class of long-lasting PAF receptor antagonists. J Lipid Mediat (1992) 0.75
The effect of diet on the transport of probucol in monkeys. Artery (1982) 0.75
A look ahead. Third-generation antihistamines. Adv Nurse Pract (1998) 0.75
Effects of combined receptor antagonists of leukotriene D4 (LTD4) and platelet-activating factor (PAF) on rhesus airway responses to LTD4, PAF and antigen. Int Arch Allergy Appl Immunol (1989) 0.75
Ultrastructural visualization of low-density lipoproteins during receptor binding and cellular endocytosis. J Ultrastruct Res (1983) 0.75
Dental malpractice claims: causes and cures. Dent Econ (1996) 0.75
High-density lipoprotein subclasses in diabetes. Am J Med (1986) 0.75
Direct effect of triiodothyronine on glucose utilization in adipocytes from obese and nonobese Zucker rats. Int J Biochem (1984) 0.75
Ultrastructure of hepatic cholesterol crystals in the hypercholesterolemic - diabetic rat. Pathol Res Pract (1983) 0.75
Causes of thrombocytopenia in a hospital population. A six-months survey of 7,750 patients. Med J Aust (1971) 0.75
Antitumor activity of a piperidine phospholipid. Arzneimittelforschung (1994) 0.75
Relationship of insulin resistance and hyperinsulinemia to blood pressure during pregnancy. J Matern Fetal Med (1997) 0.75
Structural modification of 5-aryl-2,3-dihydroimidazo[2,1-a]isoquinoline platelet activating factor receptor antagonists. J Med Chem (1993) 0.75
Hyperlipoproteinemia in spontaneously diabetic guinea pigs. Metabolism (1989) 0.75
Vesicle distribution in the arterial endothelium determined with ruthenium red as an extracellular marker. J Ultrastruct Res (1982) 0.75
Identification of a rat hepatic high density lipoprotein-binding protein. Trans Assoc Am Physicians (1987) 0.75